These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9411587

  • 21. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG, Rupp H, Maisch B.
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy.
    Agabiti-Rosei E, Muiesan ML, Salvetti M.
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S104-8. PubMed ID: 16565230
    [Abstract] [Full Text] [Related]

  • 23. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F, García González M, Domínguez Rodríguez A, Barragán Acea A, Miralles Ibarra JM, Lacalzada Almeida J, de Armas Trujillo D.
    Rev Esp Cardiol; 1997 Apr; 50 Suppl 4():74-6. PubMed ID: 9411592
    [Abstract] [Full Text] [Related]

  • 24. [Obesity and cardiac failure].
    Galinier M, Pathak A, Roncalli J, Massabuau P.
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
    [Abstract] [Full Text] [Related]

  • 25. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP.
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract] [Full Text] [Related]

  • 26. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG, Schannwell CM, Schwartzkopff B, Strauer BE.
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [Abstract] [Full Text] [Related]

  • 27. [Arterial hypertension and cardiac arrhythmias].
    Vester EG.
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E, Muiesan ML.
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Left ventricular remodeling in arterial hypertension and its therapy].
    Dúbrava J.
    Vnitr Lek; 1998 Jan; 44(1):50-6. PubMed ID: 9750485
    [Abstract] [Full Text] [Related]

  • 35. Hypertensive heart disease.
    Diamond JA, Phillips RA.
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Managing cardiovascular and renal risk: the potential of direct renin inhibition.
    Sever PS, Gradman AH, Azizi M.
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.